Status:
COMPLETED
Validation of a Smartwatch in Persons With Multiple Sclerosis
Lead Sponsor:
University of Erlangen-Nürnberg
Collaborating Sponsors:
Neurological Rehabilitation Center Quellenhof
ZTM Bad Kissingen
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is designed to validate the accuracy of steps detected by a commercially available smartwatch in persons with multiple sclerosis. Specifically, the investigators examine whether a smartwatch...
Detailed Description
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. It is one of the most common neurological diseases in young adulthood. The main symptoms of MS are gait and mob...
Eligibility Criteria
Inclusion
- Multiple Sclerosis with Expanded Disability Status Scale between 0 - 6.5
- Ability to walk 250 steps with or without an assistive device
Exclusion
- Clinically relevant cardiovascular or orthopaedic disease
- Severe polyneuropathy
- Cognitive impairment
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2019
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03750097
Start Date
May 1 2018
End Date
January 31 2019
Last Update
April 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Department of Sport Science and Sport, Gebbertstr. 123b
Erlangen, Germany, 91058